New Results
In silico investigation of the new UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 variants with a focus at the ACE2-Spike RBD interface
Bruno O. Villoutreix, Vincent Calvez, Anne-Genevieve Marcelin, Abdel-Majid Khatib
doi: https://doi.org/10.1101/2021.01.24.427939
Bruno O. Villoutreix
1Integrative Computational Pharmacology and Data Mining, INSERM UMR 1141, NeuroDiderot, Robert-Debré Hospital, Paris, France
Vincent Calvez
2Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière - Charles Foix, laboratoire de virologie, F75013 Paris, France
Anne-Genevieve Marcelin
2Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière - Charles Foix, laboratoire de virologie, F75013 Paris, France
Abdel-Majid Khatib
3Univ. Bordeaux, INSERM, LAMC, U1029, F-33600 Pessac, France
Article usage
Posted January 24, 2021.
In silico investigation of the new UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 variants with a focus at the ACE2-Spike RBD interface
Bruno O. Villoutreix, Vincent Calvez, Anne-Genevieve Marcelin, Abdel-Majid Khatib
bioRxiv 2021.01.24.427939; doi: https://doi.org/10.1101/2021.01.24.427939
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)